PubMed:20489151 / 597-911
Annnotations
GoldHamster
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T69 | 210-222 | CHEBI:18367 | denotes | phosphate (3 |
T74 | 234-243 | PR:000000182 | denotes | TGF-beta1 |
T73 | 234-243 | D053773 | denotes | TGF-beta1 |
T75 | 234-243 | D053773 | denotes | TGF-beta1 |
T80 | 270-273 | PR:000000034 | denotes | BMP |
T81 | 270-273 | P35855 | denotes | BMP |
T79 | 270-273 | CHEBI:60815 | denotes | BMP |
T82 | 274-283 | CHEBI:35222 | denotes | inhibitor |
T90 | 284-293 | Q9W741 | denotes | noggin (1 |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 0-314 | DRI_Outcome | denotes | Porcine AV cusps were cultured in a stretch bioreactor, at 10% (physiological) or 15% (pathological) stretch and 70 beats per minute for 3, 7, and 14 days, in osteogenic media supplemented with or without high phosphate (3.8 mmol/L), TGF-beta1 (1 ng/ml), as well as the BMP inhibitor noggin (1, 10, and 100 ng/ml). |
Goldhamster2_Cellosaurus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 34-35 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T9 | 147-149 | CVCL_ZS48|Finite_cell_line|Homo sapiens | denotes | 14 |
T10 | 247-249 | CVCL_6D57|Cancer_cell_line|Rattus norvegicus | denotes | ng |
T11 | 250-252 | CVCL_F566|Transformed_cell_line|Homo sapiens | denotes | ml |
T12 | 250-252 | CVCL_W799|Cancer_cell_line|Homo sapiens | denotes | ml |
T13 | 307-309 | CVCL_6D57|Cancer_cell_line|Rattus norvegicus | denotes | ng |
T14 | 310-312 | CVCL_F566|Transformed_cell_line|Homo sapiens | denotes | ml |
T15 | 310-312 | CVCL_W799|Cancer_cell_line|Homo sapiens | denotes | ml |